Log in to save to my catalogue

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SA...

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SA...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_003051f17fc447e2b1efeb8c8e2a7ebc

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

About this item

Full title

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

Publisher

London: Nature Publishing Group UK

Journal title

npj vaccines, 2021-12, Vol.6 (1), p.145-145, Article 145

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Numerous vaccine candidates against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are under development. The majority of vaccine candidates to date are designed to induce immune responses against the viral spike (S) protein, although different forms of S antigen have been incorporated. To evaluate the yield and immunogenicity of differe...

Alternative Titles

Full title

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_003051f17fc447e2b1efeb8c8e2a7ebc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_003051f17fc447e2b1efeb8c8e2a7ebc

Other Identifiers

ISSN

2059-0105

E-ISSN

2059-0105

DOI

10.1038/s41541-021-00410-8

How to access this item